Endocrine Abstracts

Introduction: Immunohistochemistry (ihc) in thyroid pathology is often recruited for differentiating between challenging benign and malignant tumors. There is no single antibody that can render definitive diagnosis. Most of the recently identified ihc markers have never been assimilated into daily clinical practice due to their low reproducibility and other associated limitations. Trop-2 ihc was recently reported as a useful tool for identifying papillary thyroid carcinoma (pt...